Ratio Therapeutics
Pharmaceuticals company with a recent SEC Form D offering.
Pharmaceuticals company headquartered in BOSTON, MASSACHUSETTS. Filed SEC Form D on 20260731 for a $70.0M Regulation D offering.
Biotech
📍 BOSTON, MASSACHUSETTS
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Ratio Therapeutics going public?
No. Ratio Therapeutics is private and has not filed to go public. There is no S-1 on file.
What is Ratio Therapeutics' valuation in 2026?
No confirmed valuation is on record for Ratio Therapeutics. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Ratio Therapeutics filed an S-1?
No public S-1 is on file for Ratio Therapeutics.
Can you buy Ratio Therapeutics stock?
No. Ratio Therapeutics is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Ratio Therapeutics on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Growth
Filed SEC Form D on 20260731 for $70.0M Regulation D offering
Last Round
Form D filing — $70M (20260731)
Fundraising Status
Form D filing · $70M
privateTotal raised $70M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Form D filing | $70M | 20260731 | — | — |
Vertical Intelligence — Biotech / Gene Therapy
Registered trials
3
2 active · 2 recruiting
Lead phase
Phase 1
most advanced registered study
Focus areas
Healthy Volunteer
Advanced Soft Tissue Sarcoma · Prostate Cancer
Latest trial start
2026-07-08
Talent Signal
No public careers page or job board could be found for Ratio Therapeutics as of 2026-09-14. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.